Pulsed-Field Electrophoresis Enhances Genome Effort

When the technique of pulsed-field gel electrophoresis (PFGE) was first described by David C. Schwartz and Charles R. Cantor almost a decade ago (Cell, 37:67-75, 1984), many molecular biologists recognized its potential immediately. A flurry of innovation in instrumentation based on the idea followed in the next half-dozen years. Despite this interest and activity, only in the past few years has PFGE secured its place as a mature, integral laboratory tool in molecular genetics generally and the

Written byFranklin Hoke
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

When the technique of pulsed-field gel electrophoresis (PFGE) was first described by David C. Schwartz and Charles R. Cantor almost a decade ago (Cell, 37:67-75, 1984), many molecular biologists recognized its potential immediately. A flurry of innovation in instrumentation based on the idea followed in the next half-dozen years. Despite this interest and activity, only in the past few years has PFGE secured its place as a mature, integral laboratory tool in molecular genetics generally and the Human Genome Project particularly.

What Schwartz and Cantor demonstrated in 1984 was that, by alternately applying two electric fields at an angle across the gel instead of using one constant field, larger DNA could be resolved than ever before--much larger. With conventional electrophoresis in a constant field, DNA fragments above a certain size co-migrate in a broad band and do not separate properly.

"The key advantage to PFGE is that you can separate ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies